As of 2024, the Current Health Expenditure Per Capita in Kenya is forecasted to be $94.92. Based on the data provided, the expected year-on-year growth rates are as follows:
2025: 2.77%
2026: 2.66%
2027: 2.57%
2028: 2.47%
The compound annual growth rate (CAGR) over the five-year forecast period from 2024 to 2028 is approximately 2.62% per year.
Future trends to watch for include potential changes in government health policies, shifts in international aid flows, and economic fluctuations that could either enhance or inhibit healthcare funding. Additionally, the global economic climate, particularly the impacts of inflation and currency fluctuations, could impact the actual per capita health expenditure going forward.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
